Negative Lung Cancer Screening Means Less Intention To Stop Smoking, Study.

It has been discovered lately that men who undergo screening and have negative results for lung cancer are not trying to give up smoking more than those predicted to have lung cancer and need follow up, according to a Dutch study.


A US study recommended screening of the lungs of heavy smokers with special type of CT scanner, which can help the detection of the cancer in its early stages and reduce its risk of dying from the disease by 20% better than using the ordinary X-ray.

To read the rest of the article, please visit:
Negative Lung Cancer Screening Means Less Intention To Stop Smoking, Study.

Transvaginal Ultrasound Is Useful For Detecting Endometrial Cancer, Study

According to a study, from the University College London, Transvaginal ultrasound features high specificity and sensitivity for diagnosing endometrial cancer. The researchers discovered that transvaginal ultrasound is useful for high-risk groups prone to endometrial cancer and especially in the management of postmenopausal females subjecting to pelvic scans for causes different from vaginal bleeding.

The most common gynecological cancer in Europe is endometrial cancer, and in many northern and western European countries it has a rising occurrence in postmenopausal females. Overall occurrence of endometrial cancer in the U.K increased from 13.5 per 100,000 in 1993 to 17.9 per 100,000 in 2005.
In order to read the rest of the article please visit:
Transvaginal Ultrasound Is Useful For Detecting Endometrial Cancer, Study

Nordion Ships The First Mo-99 Sample From Russia.

Nordion Inc., a major company providing services and products to healthcare market across the world, announced that the first sample of its Molybdenum-99 (Mo-99) has been shipped from "Isotope", Nordion’s partner in Russia. Mo-99 and other Medical isotopes are used by a wide range of hospitals and healthcare facilities in order to diagnose and treat several medical conditions, such as cardiac and neurological disorders in addition to several forms of cancer.
Back in September, Nordion and Isotope made a supply agreement for Mo-99 that extends until 2020. The recently-shipped sample will be evaluated at Nordion’s facility in Ottawa, Canada. The assessment is taking place in order to get product registration and regulatory approvals before allowing Nordion to start supplying the medical isotope in the Canadian markets.

To read of this news, please visit:

Nordion Ships The First Mo-99 Sample From Russia.

New York Times Reported Uncomfortable Questions On Breast Cancer Screening Guidelines.

According to New York Times, debates have been taking place since the release of breast cancer screening recommendations over than one year ago; it was reported that there are still "lingering, uncomfortable questions about when and how often to undergo breast cancer screenings, and how to balance the benefits of early diagnosis with the harms of mammography”.

New guidelines were released by the U.S Preventive Services Task Force in November 2009, mentioning that females with an average risk of breast cancer should start imaging for the disease at age 50 other than females at age 40. The panel recommendations mentioned that the decision to begin imaging every two years "should be an individual one" that "takes patient context into account, including the patient's values regarding the specific benefits and harms."
In order to read the rest of the article please visit:
New York Times Reported Uncomfortable Questions On Breast Cancer Screening Guidelines.

EMRs Do Not Always Mean Higher Quality Of Care, Study.

A new research, published this week in the American Journal of Managed Care, found that the adoption of electronic medical records (EMR) in U.S. hospitals has limited effect on the quality of care.


The researchers at the nonprofit Rand analyzed the quality of care at 2,021 hospitals between 2003 and 2007 across three conditions: pneumonia, heart attack, and heart failure. The number of hospitals using either basic or advanced EMRs grew from 24 % in 2003 to 38 % in 2006.

To read the rest of the article, please visit:
EMRs Do Not Always Mean Higher Quality Of Care, Study.

Texas Breast Specialists Practice Awarded The ACR’s Breast Imaging Centre of Excellence.

The American College of Radiology (ACR) has awarded Texas Breast Specialists, a related practice of Texas Oncology-Amarillo Cancer Center, the status of a “Breast Imaging Center of Excellence.”
Texas Specialists is considered to have the most developed breast screening equipment and the best diagnostic services in Amarillo. The practice provides all the screening techniques that can detect breast cancer in an earlier stage when the treatment is more effective, among these techniques, the digital screening and diagnostic mammography, breast-specific gamma imaging, breast ultrasound, stereotactic and ultrasound-guided needle and vacuum probe breast biopsies, ductography, and second opinion consultations.

To read the rest of the article, please visit:
 Texas Breast Specialists Practice Awarded The ACR’s Breast Imaging Center of Excellence.

iSoft Signs An Agreement With CliniWorks For Worldwide Distribution Of AccelFind.

iSoft, a leading Australian company providing healthcare IT solutions, announced that it has signed a new agreement with CliniWorks, a US-based healthcare IT marketing company, in order to distribute iSoft’s AccelFind software to hospitals and healthcare facilities throughout the world.
AccelFind allows its users to extract medical knowledge from any form or type of data. The knowledge can be obtained from sources such as free text notes, discharge summaries or other forms of data such as those available in electronic medical records (EMR). The recently-signed agreement will include iSoft offering its AccelFind among its Life Sciences solution, and it will provided under the ‘Powered by CliniWorks’ banner.

To read the rest of this news, please visit:
iSoft Signs An Agreement With CliniWorks For Worldwide Distribution Of AccelFind.

Philips Cooperates With German Partners To Improve MPI Technology.

Royal Philips Electronics, a major company providing medical imaging systems, has recently announced the beginning of a new German public-private partnership, which aims to improve the developments currently taking place in whole-body Magnetic Particle Imaging (MPI) systems, along with the preclinical hybrid systems that use a combination of MPI and the traditional MRI scans.

The German Federal Ministry of Education and Research committed to offer a fund of EUR 10.6 million to the consortium partners, and the total budget will be EUR 20.3 million. Philips aims to strengthen its position as a leading provider of the latest medical imaging systems. Therefore, the company is contributing the researches carried out to develop MPI; the imaging technique was designed by scientists at Philips.
In order to read the rest of the article please visit:
Philips Cooperates With German Partners To Improve MPI Technology.

New Breast MRI Imaging and Biopsy System Presented By WCA Hospital

WCA Hospital is pleased to provide Breast MRI Imaging and MRI-guided Breast Biopsy - a minimally invasive procedure in which a breast biopsy is guided by highly detailed magnetic resonance imaging. When Breast MRI scans are used along with conventional mammography, they offer valuable data for the classification and the diagnosis of breast disease.

Breast Cancer in the United States is considered the most common kind of cancer among females and also the second leading cause of death in females. But, as the result of the diagnosis in an early stage and the development in treatment, a lot of females today are cured from breast cancer. Betsy T. Wright, WCA Hospital President/CEO  mentioned "Our new technological capabilities extends the range of quality diagnostic services that WCA offers and broadens our commitment to providing our patients with access to the best possible care in this region,"
In order to read the rest of the article please visit:
New Breast MRI Imaging and Biopsy System Presented By WCA Hospital

Brain Scan Can Predict When Dyslexic Children Can Read, Study.

A new study mentioned that by a simple brain scan researchers can predict when children with dyslexia will learn to read. It is known that brain disorder makes it very hard to children even clever ones to learn how to read, which is considered as a critical reason for frustration.
Improvements of children’s reading skills can be predicted accurately by brain scans with an accuracy of 90%, according to a research published in the Proceedings of the National Academy of Science (PNAS).

To read the rest of the article,please visit:
Brain Scan Can Predict When Dyslexic Children Can Read, Study.